| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.045 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |